Show Search Form
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health | ||||||||||
answering dept sort name | Health | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Innovative Medicines and Medical Technology Review | ||||||||||
house id | 1 | ||||||||||
identifier | 121415 | ||||||||||
legislature |
|
||||||||||
parliament number | 57 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics. | ||||||||||
session |
|
||||||||||
session number | 1 | ||||||||||
tabling member constituency | East Kilbride, Strathaven and Lesmahagow | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 121415 | ||||||||||
type |
|
||||||||||
uin | 121415 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer |
|
||||||||||
creator |
|
||||||||||
publisher |
|
||||||||||
tabling member |
|